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ABSTRACT OF THE DISSERTATION 
 
Analysis and characterization of the biosynthetic pathway of Coenzyme Q in eukaryotes, and the 
role of ring precursors and key intermediates 
by 
 
Anish Nag 
Doctor of Philosophy in Chemistry  
University of California, Los Angeles, 2019 
Professor Catherine F. Clarke, Chair 
 
 
Coenzyme Q (known by various names that include ubiquinone, CoQ or simply Q) is a 
crucial redox-active lipid that consists of a fully substituted benzenoid head group and a 
polyisoprenoid tail. The benzenoid head group moiety that resembles a quinone, can undergo 
reversible redox reactions interconverting from the fully oxidized quinone through a radical 
semi-quinone intermediate to the fully reduced quinol. This structural feature aids in the essential 
role that Q plays in cellular respiration, wherein it transports electrons from NADH and 
succinate to cytochrome c (Respiratory complex I and II to III respectively in eukaryotes). Q also 
acts as a lipid soluble chain terminating anti-oxidant. Thus, complete lack of Q is embryonically 
fatal and sufficient de novo Q biosynthesis is crucial for proper health maintenance in humans. Q 
deficiency has been directly or indirectly linked to a wide spectrum of health disorders in 
humans, including kidney disease, neurodegenerative diseases, cerebellar ataxia, and 
cardiovascular complications. Additionally, decreased Q levels have been linked to aging. 
Current therapeutic strategies to treat Q deficiency related complications involve direct oral 
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supplementation of Q, which has its challenges due to the hydrophobicity and low bio-
availability of Q. Therefore, our research is aimed at characterizing the biosynthesis and 
metabolism of Q in living cells, thereby potentially leading the way to novel therapeutic 
techniques.  
Saccharomyces cerevisiae (yeast) serves as a highly useful model for research on Q, due 
to its widely studied molecular genetics and its close homology to human Q biosynthesis, 
metabolism and function.  Q biosynthesis in S. cerevisiae (which makes Q6 with six isoprene 
units, versus humans whose Q10 has ten isoprene units) takes place in the mitochondria. Chapter 
1 highlights the currently known Q biosynthetic steps along with phenotypes observed from 
deletion and malfunction of Q biosynthesis in yeast and humans. The primary precursor 
molecule that is utilized by eukaryotes to biosynthesize Q is 4-hydroxybenzoic acid (4HB). The 
latter is in turn immediately preceded by 4-hydroxybenzaldehyde (4HBz) in the Q biosynthetic 
pathway. Fourteen known proteins that localize in the mitochondria are responsible for 
catalyzing different steps in this process—Coq1-Coq11, Yah1 (ferredoxin), Arh1 (ferredoxin 
reductase), and Hfd1 (aldehyde dehydrogenase). In yeast 4HBz is biosynthesized from the 
precursor amino acid Tyrosine (Tyr). However, this pathway lacks proper characterization and 
only the deaminases Aro8 and Aro9 and the aldehyde dehydrogenase Hfd1 have been identified. 
The human homolog of Hfd1 is ALDH3A1 which can serve as a potential target when attempting 
to screen for Q deficiency in humans. 
Chapter 2 investigates the role of key proteins and intermediates in the biosynthesis of Q 
in yeast. In addition to 4HB yeast is also capable of utilizing p-aminobenzoic acid (pABA) as a 
Q ring precursor. However, the exact steps by which the two pathways converge was not fully 
characterized. It was postulated that the deamination followed by hydroxylation of the pABA 
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phenyl ring occurs via Schiff base chemistry. Additionally, high performance liquid 
chromatography tandem mass spectrometry (HPLC-MS/MS) analysis of yeast mutants with 
deletions in selected Coq genes, showed accumulation of Q intermediates. These intermediates 
included 3-hexaprenyl-4-hydroxyphenol (4-HP), 3-hexaprenyl-4-aminophenol (4-AP), demethyl 
demethoxy Q6 (DDMQ6), imino demethyl demethoxy Q6 (IDDMQ6), demethoxy Q6 (DMQ6), 
and imino demethoxy Q6 (IDMQ6). In order to test the hypothesis of the Schiff base chemistry 
responsible for Q biosynthesis from pABA, and to investigate whether the above mentioned 
intermediates are actual productive Q intermediates or just dead-end intermediates, farnesylated 
analogs (wherein the hexaprenyl tail of Q intermediates is changed to a farnesyl tail consisting of 
three isoprene units) of 4-HP, DDMQ6 and DMQ6 along with the reduced intermediate 
IDDMQ6H2, were chemically synthesized. Thus 2-farnesyl-4-dyroxyphenol (4-HFP), demethyl 
demethoxy Q3 (DDMQ3), demethoxy Q3 (DMQ3) and reduced imino demethyl demethoxy Q3 
(IDDMQ3H2) were correspondingly obtained. These intermediates were fed to yeast in 
biochemical feeding assays and their corresponding potential transformation to Q3 was analyzed 
via HPLC-MS/MS studies. DMQ3 showed ready conversion to Q3. However, DDMQ3 showed 
very limited Q3 generation, whereas, 4-HFP and IDDMQ3H2 failed to show detectable levels of 
Q3. Thus the role of DMQ6 as a Q biosynthetic intermediate was further elucidated.  
It was demonstrated by Dr. Fabien Pierrel’s research group that the Schiff base chemistry 
hypothesis for the convergence of the pABA and 4HB pathways leading to Q biosynthesis, was 
incorrect, and the deamination of the ring of pABA occurs further upstream than formerly 
postulated. Therefore efforts to further synthesize and investigate farnesylated analogs of Q 
intermediates were postponed and instead investigations were carried out to test the role of ring 
precursors in addition to 4HB and pABA in Q biosynthesis. Chapter 3 gives details of the studies 
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conducted on selected alternate Q ring precursors, and the discovery of kaempferol (a plant 
derived flavonol), as a novel Q ring precursor in mammalian cells. Mouse kidney proximal 
tubule epithelial (Tkpts) cells and human embryonic kidney cells 293 (HEK 293) were treated 
with several types of polyphenols, and kaempferol produced the largest increase in Q levels. 
Experiments with stable isotope 13C-labeled kaempferol demonstrated a previously unrecognized 
role of kaempferol as an aromatic ring precursor in Q biosynthesis. Investigations of the 
structure-function relationship of related flavonols showed the importance of two hydroxyl 
groups, located at C3 of the C ring and C4′ of the B ring, both present in kaempferol, as 
important determinants of kaempferol as a Q biosynthetic precursor. Concurrently, through a 
mechanism not related to the enhancement of Q biosynthesis, kaempferol also augmented 
mitochondrial localization of Sirt3. The role of kaempferol as a precursor that increases Q levels, 
combined with its ability to upregulate Sirt3, identify kaempferol as a potential candidate in the 
design of interventions aimed on increasing endogenous Q biosynthesis, particularly in kidney. 
In addition to kaempferol, other phenolic molecules were previously shown to act as Q 
ring precursors in yeast and mammalian cells. This included p-coumaric acid. Chapter 4 reports a 
detailed investigation into the role of p-coumaric acid as a Q ring precursor in yeast. Stable 
isotope labeled [13C6-ring]-p-coumaric acid was chemically synthesized. This was tested on 
BY4741 and W303 genetic backgrounds of wild type (WT) yeast to analyze corresponding 
[13C6-ring]-Q levels via HPLC-MS/MS. Different growth media conditions and times of 
incubation were utilized in order to fully assess the role of p-coumaric acid as an alternate Q ring 
precursor. It was discovered that the W303 genetic background of yeast has a much higher 
efficiency of p-coumaric acid uptake and subsequent conversion to Q. Furthmore, attempts were 
made to test the pathway by which p-coumaric acid is biosynthesized to Q. It was postulated that 
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this occurs via intermediary biosynthesis of the former to 4HB. To investigate this possibility the 
Hfd1 gene was knocked out in the W303 genetic background, and the corresponding hfd1 null 
strain was assayed with [13C6-ring]-p-coumaric acid.  
Chapter 5 provides insight and perspectives into projects being currently pursued and 
potential experiments to be conducted in the future. In particular, we are probing further into the 
role of kaempferol as a Q ring precursor in mammalian cells. It was hypothesized that the B ring 
of kaempferol underwent cleavage from the rest of the molecule and was utilized to generate the 
ring of Q in mammalian cells. This explanation was further strengthened when Dr. Gilles Basset 
was able to confirm the utilization of the B ring of kaempferol to generate Q in Arabidopsis 
thaliana. Moreover, Dr. Bassett showed that this occurs through a peroxidative cleavage 
mechanism, whereby the B ring of kaempferol is converted to 4HB, which in turn is used to 
generate Q. Attempts are being made to probe into a similar potential peroxidative mechanism 
occurring in mammalian cells. An in vitro peroxidation assay similar to the one used by Dr. 
Bassett is in the process of being set up on mammalian cell extracts incubated with kaempferol. 
Methods have been generated to detect 4HB (synthesized by kaempferol peroxidation in the cell 
extracts) by HPLC-MS/MS via a derivatization strategy. In addition, mouse kidney cells grown 
in presence of kaempferol with the B ring selectively labeled with stable 13C isotope (generated 
by Dr. Bassett), have shown production of 13C stable isotope ring labeled Q.  
Finally, the Appendix contains two additional publications.  The first explores alternative 
splicing in yeast and the role it plays in Q biosynthesis. PTC7 encodes the phosphatase 
responsible for the dephosphorylation of Coq7 undergoes alternative splicing, which is rare in 
yeast.  The study also implicated SNF2 as the gene that is responsible for this alternative splicing 
event and showed that deletion of SNF2 leads to increased Q levels in yeast. The second 
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publication explores the rescue of the clinical phenotypes associated with Coq6 deletion in mice 
by supplementation with 2,4-dihydroxybenzoic acid. In particular it was shown that steroid 
resistance nephrotic syndrome which develops in mice with Coq6 deletion, can be ameliorated 
by treatment with 2,4-dihydroxybenzoic acid.   
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Introduction: 
 
Ubiquinone, (also known as Coenzyme Q, CoQ or simply Q), is a lipid with an essential role in 
the mitochondrial electron transport chain of eukaryotes as well as cellular respiration in the 
plasma membrane of prokaryotes (1). The structure of Q consists of a benzenoid head group 
moiety that resembles a fully substituted quinone, and a hydrophobic isoprenoid tail that can 
vary in length and the number of isoprene units constituting it, depending on the species in which 
it is found. The quinone group undergoes reversible electron transfers, and can interchange 
between the fully oxidized quinone and the fully reduced quinol (Figure 1). At the same time, the 
isoprenoid lipophilic tail functions to anchor Q in the membrane. In eukaryotes, Q performs the 
critical role of shuttling electrons from either Complex I or Complex II to Complex III/bc1 
complex. The transfer of electrons from Q to the bc1 complex is coupled to a proton gradient that 
is set up across the membrane via the Q cycle mechanism that was first proposed by Mitchell (2).  
 
The redox properties of Q also allow it to function as a lipid soluble chain terminating 
antioxidant. Q functions either directly, by scavenging lipid peroxyl radicals (4), or indirectly, by 
discarding α-tocopherol radicals to regenerate α-tocopherol (5, 6). Additionally, Q protects cell 
and cell organelles from damage caused by the autoxidation of polyunsaturated fatty acids and 
other oxidative stress (7). Q is present in many eukaryotic intracellular membranes, which 
include the plasma membrane, wherein it is capable of scavenging ascorbate free radicals in 
conjunction with the plasma membrane electron transport chain (8, 9). In the plasma membrane 
of prokaryotes, Q participates in the maintenance and function of the catalytic activity of 
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DsbA/DsbB disulfide bond forming proteins and enzymes (10), and Q-deficient Escherichia coli 
(E. coli) strains are hypersensitive to thiol exposure.  
     
The biosynthesis of Q (Figure 2) as hypothesized in 2010, involved a series of intermediates, 
starting from either 4-hydroxy benzoic acid (4HB) or para amino benzoic acid (pABA), in the 
case of yeast (3). The pathway was conceived from the characterization of accumulating Q 
biosynthetic intermediates in studies with Saccharomyces cerevisiae (12) and E. coli (13) Q-
deficient mutants (17). Coq8 over-expression (hcCOQ8) in certain coq null strains led to the 
accumulation of novel intermediates, which suggested the existence of branches in the Q 
biosynthetic pathway. For example, in the presence of hcCOQ8, coq6 or coq9 null mutants 
accumulated 4-AP (derived from pABA), and 4-HP (derived from 4HB), indicating that in some 
cases decarboxylation and hydroxylation at position 1 of the ring might occur before the Coq6 
hydroxylation step. Other intermediates that were found to accumulate were demethyl 
demethoxy Q6 (DDMQ6), imino demethyl demethoxy Q6 (IDDMQ6), demethoxy Q6 (DMQ6), 
and imino demethoxy Q6 (IDMQ6). The exact mechanism by which the pathway deriving from 
pABA converges with that deriving from 4HB is unknown. It was postulated and previously 
published that a potential Schiff base mechanism chemistry is responsible for the deamination 
and hydroxylation of the phenyl ring of pABA as shown by the purple dotted lines in Figure 2 
(18). Moreover the exact role of some of the aforementioned intermediates in overall Q 
biosynthesis was unknown. Two such intermediates are 4-HP and 4-AP. An approach to gather 
further insight into the role of these intermediates as well as the convergence of the pathway 
originating from pABA with that originating from 4HB, involves generation of farnesylated 
analogs of these intermediates. Farnesylated analogs where the isoprenoid tail is substituted for a 
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farnesyl tail instead of a hexaprenyl one, have previously been used for various tests studies (14, 
15). In particular, it has been demonstrated that farnesylated analogs of Q intermediates are 
converted to Q3 in R. rubrum (16). In this current study, the intermediates 2-farnesyl-4-
hydroxyphenol (4-HFP), demethyl demethoxy Q3 (DDMQ3), demethoxy Q3 (DMQ3) and imino 
demethyl demethoxy Q3H2 (IDDMQ3H2) were chemically synthesized and used in biochemical 
feeding assays on Saccharomyces cerevisiae wild type strains. Thus we are trying to further 
characterize the pathway of Q biosynthesis in yeast, by analyzing whether these intermediates 
are converted to Q3 by wild type yeast strains via subsequent HPLC-MS/MS analysis.  
 
Results: 
 
Based on the previously investigated approach to synthesize the farnesylated analogs of Q 
intermediates (14, 15), a Stille coupling reaction to attach the farnesyl “tail” on the 
corresponding brominated substrates was devised. Attempts made to synthesize 2-bromo-4-
hydroxyphenol 1, the corresponding brominated starting material through Stille coupling for 4-
HFP, by direct bromination of hydroquinone 2 (Scheme 1), was unsuccessful and 1 could not be 
isolated.  
 
Therefore 1 was commercially obtained and was subjected to an acetylation reaction (Scheme 2). 
It was treated with acetic anhydride, triethyl amine and catalytic amounts of N,N-dimethyl 
aminopyridine to give the acetylated product 3. 
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The tributyl farnesyl stannane 4 required for the Stille coupling was prepared by treating 
commercially available trans,trans- farnesyl chloride 5, with tributyltin hydride and LDA (11), 
(Scheme 3). The Stille coupling was then carried out on 3, using tetrakis triphenylphosphine 
palladium (0) catalyst, to give the farnesylated product 6 (Scheme 4). 
 
Compound 6 was then deacetylated by basic hydrolysis with potassium carbonate, to give the 
required 4-HFP (Scheme 5). Stronger basic hydrolysis conditions involving lithium hydroxide 
under reflux, seemed to decompose the starting material 6. The 4-HFP thus synthesized was 
stored under argon at -20 oC and was found to be susceptible to auto-oxidation to the 
corresponding quinone. However, either the hydroquinone or the quinone is a suitable substrate 
for testing in feeding assays with yeast, so steps were not taken to prevent the auto-oxidation of 
4-HFP.  
 
Simultaneously a strategy was designed to synthesize 4-amino-3-bromo-6-methoxyphenol 7 that 
would serve as the brominated starting material for coupling with tributyl farnesyl stannane to 
give IDDMQ3H2 (19) (Scheme 6). Commercially available 3,5-difluorophenol 8 was treated with 
concentrated nitric acid to give the nitrated product 9. The phenol was then treated with 
chloromethyl methyl ether, in presence of N,N-diisopropylethylamine, to give the acetal 
protected product 10. This was then treated with ammonia solution in methanol to give the amine 
11, which on treatment with t-butyl nitrite and copper (I) bromide, undergoes a Sandmeyer type 
reaction to give the brominated product 12. This when treated with sodium methoxide solution 
(25 wt% in methanol), gives the methoxy benzene product 13. Subsequent deprotection with 
trifluoroacetic acid gives the phenol 14, which on reduction gives our required product 7. The 
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bromobenzene 7 was then directly subjected to the Stille coupling with tributyl farnesyl 
stannane, without acetylating it first, in order to minimize the total number of steps required and 
also to reduce possible losses in yield (Scheme 7). Coupling of 7 with tributyl farnesyl stannane, 
catalyzed by tetrakis triphenylphosphine palladium (0) yielded the required IDDMQ3H2. The 
final product was stored under argon at -20 oC. However, it was found to be extremely prone to 
decomposition and the overall synthesis had to be reattempted a second time in order to use fresh 
stocks of IDDMQ3H2 in the subsequent yeast feeding studies.  
 
A scheme was also set up for synthesizing DDMQ3 starting from vanillin 15 (Scheme 8) (14). 
Vanilin 18, was brominated to give 19, which was oxidized through a Dakin type oxidation 
approach into 20. This was then acetylated to give 21, which was subjected to the Stille coupling 
step with tributyl farnesyl stannane to give 22, which yielded DDMQ3 on deacytalion and basic 
work up with 1M NaOH. 
 
DMQ3 was synthesized from the commercially available compound 23 (Scheme 9) (14). 
Oxidation of 23 was carried out using Fremy’s salt to yield the quinone 24. Subsequent 
condensation of the quinone 24 in presence of boron trifluoride etherate and farnesol yielded the 
required product DMQ3. 
 
Subsequently tests were carried out using the four synthetic farnesylated analogs 4-HFP, 
DDMQ3, DMQ3, and IDDMQ3H2 on WT yeast in order to assess the conversion of the analogs 
into Q3. BY4741 WT and W303 WT were fed EtOH solutions of the analogs at a final 
concentration of 10 µM. The samples were collected at periodic time points after addition of 
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treatment and subsequently the lipid content of the samples were extracted. The lipid extracts 
were prepared for reverse phase analysis by HPLC-MS/MS and were injected into a 4000 Qtrap. 
Standards of the analogs DDMQ3 (Figure 3) and DMQ3 (Figure 4), and the Q species Q3 (Figure 
5) and Q6 (Figure 6) produced characteristic chromatograms when analyzed via reverse phase 
HPLC-MS/MS. Subsequent Q content analysis of the yeast samples showed almost 1000-fold 
higher Q3 levels in both the BY4741 and W303 strains that were treated with DMQ3 versus those 
treated with DDMQ3 (Figure 7, A and B). There was also a time dependent increase in Q3 levels 
with the samples collected at 48 hour time point showing the highest values of Q3. The total 
DDMQ3 and DMQ3 contents in the samples were also analyzed and it was observed that both the 
yeast strains had almost 100-fold higher DMQ3 levels when treated with DMQ3 compared to 
DDMQ3 levels when treated with DDMQ3 (Figure 8, A and B). There was also a steady decrease 
in the levels of both the intermediate analogs during the later time points. Q3 was not detected in 
both BY4741 WT and W303 WT yeast treated with 4-HFP and IDDMQ3H2 separately (data not 
shown). Q3 was also not detected in the EtOH treated vehicle control samples (data not shown). 
Steady state endogenous Q6 content was also measured and intriguingly it was observed that the 
DDMQ3 treated samples had lower Q6 content compared with the DMQ3 treated samples (Figure 
9, A and B). This effect was especially pronounced in the W303 WT compared to the BY4741 
WT yeast. The Q6 content was seen to decrease over time in both the yeast strains and both 
treatment conditions. The levels for DMQ6 and DDMQ6 were not significantly different in the 
yeast treated with EtOH serving as vehicle control (Figure 10, A and B). 
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Discussion: 
 
In order to further characterize the biosynthetic pathway of Q in yeast, a number of intermediates 
that were previously shown to accumulate in coq null strains were targeted. Farnesylated analogs 
of these intermediates were chemically synthesized. These synthetic analogs thus obtained were 
4-HFP, DDMQ3, DMQ3 and IDDMQ3H2. The primary synthetic route employed to achieve the 
final compounds, involved modifications and derivatizations of phenyl rings to obtain the 
required substituents in the correct positions on the ring. The penultimate step generally involved 
a Stille coupling reaction that was employed to attach the farnesyl tail in the right position 
replacing a bromine on the ring. In the case of 4-HFP synthesis, direct bromination of 
hydroquinone was unsuccessful, possibly due to auto-oxidation of hydroquinone into the fully 
oxidized quinone which would in turn not support the Friedel-Craft’s bromination of the aryl 
ring and also is prone to polymerization. The synthesis of DMQ3 differed from the rest of the 
analogs, because of the absence of the Stille coupling reaction. Instead a boron trifluoride 
mediated enone condensation reaction was utilized to attach the farnesyl tail at the required 
position on the ring.   
 
4-HFP was highly prone to aerial auto-oxidation. However, measures were not taken to prevent 
oxidation since yeast is capable of uptaking and utilizing both the oxidized and reduced 
intermediates of Q. All the intermediate analogs thus synthesized, were stored under argon at -20 
oC. However, despite these measures IDDMQ3H2 was found to be extremely susceptible to 
decomposition. Hence, fresh synthesis was required for immediate use in yeast feeding assays.  
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BY4741 WT and W303 WT yeast strains were selected for the feeding assays with the synthetic 
intermediate analogs. The analogs were dissolved in EtOH and were added to the yeast samples 
at a final concentration of 10 µM such that the final volume of EtOH that was added remained 
consistent in all the samples. The same volume of EtOH was added in the samples serving as 
vehicle control. Q3 levels detected in the yeast treated with both DMQ3 and DDMQ3 increased 
consistently with time. This is expected since Q3 is not the naturally occurring Q in yeast, and 
therefore the cells would be more efficient at producing Q6 instead at earlier periods of growth. 
Q3 contents were also observed to be 1000-fold higher in the yeast treated with DMQ3 than those 
treated with DDMQ3. One possibility for explaining this observation is the electrophilic stress 
that can be created by DDMQ3 on the yeast, due to the potential role that DDMQ3 can play as an 
electrophile in Michael addition type reactions with cellular nucleophiles. This assumption can 
be further supported by the much higher uptake of DMQ3 by both the WT yeast strains compared 
with DDMQ3. In addition, Q6 levels were also observed to be lower in the DDMQ3 treated 
samples, further supporting the potential toxicity of this particular molecule. No Q3 was observed 
in the cells treated with 4-HFP and IDDMQ3H2. This result can also be explained by the possible 
toxicity and electrophilic stress created by these two molecules. Additionally, there is the 
possibility that these molecules are not viable intermediates that get converted to Q, and are 
instead merely dead-end intermediates along the Q biosynthetic pathway branch points. The Q6 
content was observed to decrease with time. This result has been previously observed as well, 
however, there aren’t any clear explanation to explain this observation. One possibility is that the 
yeast cell walls become more rigid and impermeable with time, which would make the cells 
harder to lyse during the lipid extraction step. This can consequently decrease the cellular lipids 
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that are actually extracted. Possible solutions to avoid this would be to use beads when lysing the 
cells with methanol and to use longer and more vigorous vortex conditions. 
 
A concurrent and independent study led by Dr. Fabien Pierrel showed that the deamination of the 
phenyl ring of pABA occurs further upstream than our original postulate (21). They utilized 
stable isotope labeled H2
18O to demonstrate that water plays a nucleophilic role in the 
deamination and hydroxylation of the C-4 position on the ring of pABA, a process which in turn 
is catalyzed by Coq6. Thus at that point there wasn’t enough evidence supporting the theory that 
the deamination of pABA occurs via a Schiff base mediated chemistry. Further efforts to verify 
this premise can be undertaken in the future by utilizing intermediate analogs that can potentially 
avoid causing electrophilic stress and toxicity on the yeast.  
 
Materials and methods: 
 
Chemical synthesis of Q intermediates 
All reagents for organic synthesis were purchased from Aldrich and used as received unless 
otherwise stated. Dichloromethane, hexamethylphosphoric triamide, and triethylamine were 
distilled from calcium hydride. Unless specified as dry, the solvents were of unpurified reagent 
grade. All air- or water-sensitive reactions were carried out under positive pressure of argon in 
oven-dried glassware. Reactions were followed by TLC using Whatman precoated plates of 
silica gel 60 with fluorescent indicator (0.25 mm). Reactions forming quinones were followed by 
leucomethylene blue stain. Flash chromatography was performed on Davisil Grade 643 silica gel 
(230–400 mesh). NMR spectra were measured on a Bruker AM360, ARX400, or ARX500 
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spectrometer and were recorded in ppm using the solvent signal as an internal standard. Mass 
spectra and high resolution mass spectra were recorded on a VG Autospec and are reported in 
units of mass to charge (m/z). High resolution mass spectra were re-corded with an EI source. 
Yeast media and supplies were obtained from Thermo Fischer Scientific. 
Synthesis of 1,4-diacetoxy-2-bromobenzene 3: The synthesis of 3 was carried out using methods 
similar to those highlighted in (14). Briefly 2-Bromo-4-hydroxyphenol (216 mg, 1.15 mmol) was 
suspended in CH2Cl2 (2.5 ml). Triethylamine (0.56 ml, 4.12 mmol) and acetic anhydride (0.33 
ml, 3.44 mmol) were then added, followed by 4-(dimethylamino) pyridine (15 mg). The reaction 
was allowed to proceed for 7 hours at room temperature. The reaction was quenched with 
NH4Cl, and the CH2Cl2 was removed in vacuo. The residue was extracted with ethyl acetate (2 X 
5 ml), and the combined extracts were washed with brine (5 ml), dried over MgSO4, filtered, and 
concentrated. Flash chromatography (R factor = 0.3, 8:2 hexanes/ethyl acetate) was performed to 
obtain 255 mg (94% yield) colorless oil 3. 1H NMR (CDCl3, 360 MHz) δ: 2.22 (s, 3H); 2.28 (s, 
3H); 6.58 (m, 2H); 6.95 (s, 1H). 13C NMR (CDCl3, 90 MHz)  
δ: 20.21; 20.82; 105.65; 116.73; 117.19; 135.56; 148.66; 152.48; 167.65; 168.73. HRMS Calcd 
for [C10H9BrO4]
+: 271.97. Found: 271.98. 
Synthesis of tributyl farnesyl stannane 4: The synthesis of 4 was carried out using commercially 
available 5 as the starting material according to (11).  
Synthesis of 1,4-diacetoxy-2-farnesylbenzene 6: The synthesis of 6 was carried out using 
methods similar to those highlighted in (14). Briefly, Tetrakis(triphenylphosphine) palladium (0) 
((Pd(PPh3)4; 23 mg, 0.020 mmol) was dissolved in hexamethylphosphoric triamide (HMPA; 1.0 
ml), in a Schlenk tube under argon in a glove box. Compound 3 (273 mg, 1.00 mmol) was 
dissolved in HMPA (1.0 ml), and the resulting solution was added via syringe to the solution 
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containing Pd(PPh3)4. A solution of 4 (743 mg, 1.5 mmol) dissolved in HMPA (1.5 ml) was then 
added to this reaction mixture. The reaction vessel was sealed under argon, removed from the 
glove box, and heated at 65 °C in a sand bath for 48 h. The reaction was then quenched with 
saturated NH4Cl (3 ml) and extracted with ether (3 X 5 ml). The ethereal layers were washed 
with H2O (5 ml) and brine (5 ml), dried over MgSO4, filtered, and concentrated. Flash 
chromatography was performed (R factor = 0.5, 9:1 hexanes/ethyl acetate) to give  
118 mg (45% yield) of pale yellow oil 1,4-diacetoxy-2-farnesyl-benzene 6. 1H NMR (CDCl3, 
360 MHz) δ: 1.57 (s, 6H); 2.01 (m, 8H); 2.22 (s, 3H); 2.28 (s, 3H); 3.20 (d, 2H, J = 7.2 Hz); 5.05 
(m, 2H); 5.15 (m, 1H); 6.45 (m, 2H); 6.50 (s, 1H). 13C NMR (CDCl3, 90 MHz) δ: 13.45; 15.83; 
16.10; 17.11; 17.42; 20.59; 21.01; 25.41; 26.32; 26.37; 26.69; 27.49; 28.51; 39.53; 39.64; 
104.00; 113.69; 120.21; 123.57; 124.23; 131.11; 135.05; 135.49; 135.60; 137.32; 148.47; 
151.49; 168.63; 169.32. HRMS Calcd for [C25H34O4]
+: 398.2563. Found: 398.2571. 
Synthesis of 2-farnesyl-4-hydroxyphenol 4-HFP: The synthesis of 4-HFP was carried out using 
methods similar to those highlighted in (14). Briefly LiAlH4 (67 mg, 1.75 mmol) was suspended 
in ether (5 ml) and cooled to 0 °C. 1,4-diacetoxy-2-farnesylbenzene (130 mg, 0.350 mmol) was 
dissolved in ether (10 ml) and added dropwise to the suspension. The resulting reaction mixture 
was stirred for 1 hour. The reaction was quenched with water (5 ml) and then 1 M NaOH (5 ml), 
followed by water (5 ml) and allowed to warm to room temperature. A colorless precipitate 
formed and was extracted with ether (2 X 15 ml), and the combined ethereal extracts were 
washed with brine (30 ml), dried over MgSO4, filtered, and concentrated. The expected 
hydroquinone was oxidized during basic work-up, and a brown oil 4-HFP was obtained (82 mg, 
80% yield). 1H NMR (CDCl3, 360 MHz) δ: 1.55 (s, 6H); 1.58 (s, 3H); 1.63 (s, 3H); 2.00 (m, 8H); 
3.08 (d, 2H, J = 7.2 Hz); 5.06 (m, 2H); 5.13 (m, 1H); 5.85 (m, 2H); 6.22 (s, 1H). 13C NMR 
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(CDCl3, 90 MHz) δ: 15.96; 16.08; 17.60; 25.63; 26.32; 26.61; 27.07; 39.56; 39.61; 101.01; 
117.62; 123.67; 124.27; 131.18; 132.73; 135.33; 140.05; 146.34; 158.80; 182.11; 187.64. HRMS 
Calcd for [C21H28O2]
+: 312.219. Found: 312.218. 
Synthesis of 4-amino-5-farnesyl-3-methoxyphenol IDDMQ3H2: First 7 was synthesized 
according to (19) with no modifications. 7 was then subjected to Stille coupling similar to the 
synthesis of 6 to obtain IDDMQ3H2 as a brown oil (65 mg, 39% yield). 1H NMR (CDCl3, 360 
MHz) δ: 1.66 (s, 6H); 1.78 (s, 3H); 2.03 (s, 3H); 2.15 (m, 8H); 3.18 (d, 2H, J = 7.2 Hz); 3.75 (s, 
3H); 5.26 (m, 2H); 5.33 (m, 1H); 6.15 (s, 1H); 6.32 (s, 1H). 13C NMR (CDCl3, 90 MHz) δ: 
17.96; 18.08; 18.60; 25.69; 26.72; 27.61; 28.07; 40.56; 40.61; 62.69; 111.01; 119.62; 124.67; 
126.27; 132.18; 133.73; 137.33; 142.05; 148.34; 168.80; 172.11; 188.64. HRMS Calcd for 
[C22H31O2]
+: 297.212. Found: 297.212. 
Synthesis of 2-methoxy-6-farnesyl-1,4-benzoquinone DDMQ3: The synthesis of DDMQ3 was 
carried out according to (14) without any modification.  
Synthesis of 2-methoxy-6-farnesyl-5-methyl-1,4-benzoquinone DMQ3: The synthesis of DMQ3 
was carried out according to (14) without any modification.  
Yeast strains and growth media 
Sachharomyces cerevisiae wild type strains from two different genetic backgrounds were used: 
BY4741 (MAT a his3Δ0 leu2Δ0 met15Δ0 ura3Δ0) and W3031B (MAT α ade2-1 his3-1,15 leu2-
3,112 trp1-1 ura3-1). YPD medium (2% dextrose, 1% yeast extract and 2% peptone) was 
prepared as described (20). Solid plate medium included the stated components plus 2% Bacto 
agar. 
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Preparation of stock solutions for compounds added 
The synthetic analogs 4-HFP, DDMQ3, DMQ3 and IDDMQ3H2 were freshly dissolved in 
absolute EtOH. The concentration of each stock solution thus obtained were adjusted so that 
addition of 9 µL of each corresponding EtOH stock solution in 6 mL YPD liquid media would 
result in a final concentration of 10 µM for each compound. 
Farnesylated analogs feeding assay 
Yeast colonies from YPD plate medium were first inoculated into 125 mL Erlenmeyer flasks 
containing 30 mL YPD liquid medium. Following overnight incubation with shaking (250 rpm) 
at 30 oC, the yeast cells were inoculated into fresh 6mL liquid YPD medium in 18x150 mm 
borosilicate test tubes. The inoculation was performed so that the final OD600 of the yeast cells in 
6mL liquid YPD medium in each test tube is 0.1. The tubes with the yeast were further incubated 
by shaking (250 rpm) at 30 oC slanted at a 45o angle. The OD600 the yeast cultures in the test 
tubes were monitored till an OD600 of 0.5 was reached. At that time point 9 µL of the EtOH stock 
solutions of the compounds of interest were added to the tubes. The tubes with the yeast were 
incubated with shaking under the same conditions as mentioned previously. At 4, 8, 12, 24, and 
48 hours after addition of the treatments, the tubes were removed from the incubator. The OD600 
at each time point for each yeast sample was measured, 5mL of the vortexed liquid yeast culture 
was withdrawn into fresh 10mL centrifuge tubes. The tubes were centrifuged at 3000xg rpm for 
5 minutes, and the liquid media was aspirated out to obtain yeast cell pellets. The pellets thus 
obtained were stored at -20 oC. The experiment was conducted in triplicates for each time point, 
yeast strain and treatment added.  
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Lipid extraction of yeast cell pellets 
Lipid extractions of the yeast cell pellets were performed similar to the description in (17). 
Briefly the cell pellets were thawed on ice and then suspended in 2 ml of methanol Q4 was added 
as an internal standard for the determination of Q6 content in the lipid extracts. The tubes were 
vortexed at maximum intensity for 30 seconds followed by addition of 2 mL of petroleum ether. 
This was followed by another round of vortex as before, after which the upper petroleum ether 
layer was removed from the phase boundary and transferred to a fresh tube. The petroleum ether 
addition, vortex, and removal of the upper petroleum ether layer was repeated for a total of two 
cycles. The petroleum ether solutions were consolidated for each sample, and the solvent was 
evaporated under a stream of nitrogen gas. 
HPLC-MS/MS analysis to measure Q and Q intermediates  
The HPLC-MS/MS analysis to quantify Q from the yeast lipid extracts previously obtained was 
carried out as described in (17). Briefly, the dry lipid extracts were first resuspended in 200 µL 
benzoquinone solution (0.1 mg/mL in EtOH). This was done to ensure complete oxidation of all 
the lipids which simplifies the subsequent detection and quantification process. a 4000 QTRAP 
linear MS/MS spectrometer from Applied Biosystems (Foster City, CA) was used. Applied 
Biosystem software, Analyst version 1.4.2, was used for data acquisition and processing. A 
binary HPLC solvent delivery system was used with a Luna phenyl-hexyl column (particle size 5 
µm, 100 × 4.60 mm; Phenomenex) for yeast cell lipid extracts. The mobile phase consisted of 
solvent A (methanol:isopropanol, 95:5, with 2.5 mM ammonium formate) and solvent B 
(isopropanol, 2.5 mM ammonium formate). For separation of yeast quinones, the percentage of 
solvent B increased linearly from 0 to 5% over 6 min, and the flow rate increased from 600 to 
800 µL/ min. The flow rate and mobile phase were linearly changed back to initial condition by 
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7 min. All samples were analyzed in multiple reaction monitoring mode; multiple reaction 
monitoring transitions were as follows: m/z 591/197.1 (Q6 ); m/z 608/197.1 (Q6  with ammonium 
adduct); m/z 387/197.1 (Q3); m/z  404/197 (Q3 with ammonium adduct); m/z 357/167.1 (DMQ3); 
m/z  174/167.1 (DMQ3 with ammonium adduct); m/z 342.2/153.1 (DDMQ3); m/z 359.2/153.1 
(DDMQ3 with ammonium adduct). 
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Figure 1. Reversible oxidation of Q. Coenzyme Q can undergo transformation from the fully 
oxidized ubiquinone form to the fully reduced ubiquinol form via a semi-oxidized semiquinone 
radical intermediate. The polyisoprenoid tail is represented by R, where the value of n specifies 
the number of isoprene units and can range from 6 to 10 in living species.  
 
 
 
 
 
 
 
 
 
35 
 
 
 
Figure 2. Previously postulated Q6 biosynthetic pathway in S. cerevisiae. The Q biosynthetic 
pathway is shown in blue oroginating from 4HB (4-hydroxybenzoic acid). Alternatively, the red 
pathway indicates that pABA (para-aminobenzoic acid) is utilized as the ring precursor for Q. In 
the presence of hcCOQ8, coq6 or coq9 null mutants accumulate 4-AP (deriving from pABA), 
and 4-HP (deriving from 4HB). Purple dotted arrows illustrate the replacement of the C4-amine 
with a C4-hydroxyl and correspond to a proposed C4-deamination/deimination reaction, 
resulting in the convergence of the 4HB and pABA pathways. A possible mechanism to replace 
the C4-imino group with the C4-hydroxy group is shown in purple brackets for IDMQ6 but 
could also occur on IDDMQ6 (not shown). Several steps defective in the coq9 null strain are 
designated with red asterisks. Intermediates previously detected are shown in bold: 4-AP (3-
hexaprenyl-4-aminophenol); DDMQ6H2, the reduced form of demethyl-demethoxy-Q6; DMQ6, 
demethoxy-Q6; DMQ6H2, demethoxy-Q6H2 (the reduced form of DMQ6); HHAB, 3-hexaprenyl-
5-hydroxy-4-aminobenzoic acid; HMAB, 3-hexaprenyl-5-methoxy-4-aminobenzoic acid; 4-HP 
(3-hexaprenyl-4-hydroxyphenol); IDMQ6, (4-imino-demethoxy-Q6); IDMQ6H2, 4-amino 
demethoxy-Q6H2 (the reduced form of IDMQ6). Parentheses designate intermediates that have 
not been detected yet (18).
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                                                                   [M+1] = 345.2                                                        [M+1] = 153.2 
 
 
Figure 3. Chromatogram obtained from the HPLC-MS/MS analysis of DDMQ3 standard. 
The transition detected between the precursor and the product tropylium cation is shown.   
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                 [M+1] = 357.2             [M+1] = 167.2 
 
 
Figure 4. Chromatogram obtained from the HPLC-MS/MS analysis of DMQ3 standard. 
The transition detected between the precursor and the product tropylium cation is shown.   
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                 [M+1] = 387.2           [M+1] = 197.1 
 
 
Figure 5. Chromatogram obtained from the HPLC-MS/MS analysis of Q3 standard. The 
transition detected between the precursor and the product tropylium cation is shown.   
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                 [M+1] = 591.2             [M+1] = 197.1 
 
 
Figure 6. Chromatogram obtained from the HPLC-MS/MS analysis of Q6 standard. The 
transition detected between the precursor and the product tropylium cation is shown.   
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Figure 7. Q3 content measured in yeast treated with DDMQ3 and DMQ3. (A) Q3 levels 
observed in BY4741 WT (blue) and W303 WT (red) treated with DDMQ3 (B) Q3 levels 
observed in BY4741 WT (blue) and W303 WT (red) treated with DMQ3. Error bars represent 
S.D. (n = 3).  
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Figure 8. DDMQ3 and DMQ3 content measured in yeast treated with DDMQ3 and DMQ3 
respectively. (A) DDMQ3 levels observed in BY4741 WT (blue) and W303 WT (red) treated 
with DDMQ3 (B) DMQ3 levels observed in BY4741 WT (blue) and W303 WT (red) treated with 
DMQ3. Error bars represent S.D. (n = 3). 
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Figure 9. Q6 content measured in yeast treated with and DDMQ3 and DMQ3. (A) Q6 levels 
observed in BY4741 WT (blue) and W303 WT (red) treated with DDMQ3 (B) Q6 levels observed 
in BY4741 WT (blue) and W303 WT (red) treated with DMQ3. Error bars represent S.D. (n = 3). 
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Figure 10. DDMQ6 and DMQ6 content measured in yeast treated with EtOH. (A) DDMQ3 
levels observed in BY4741 WT (blue) and W303 WT (red) treated with EtOH (B) DMQ3 levels 
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observed in BY4741 WT (blue) and W303 WT (red) treated with EtOH. Error bars represent 
S.D. (n = 3). 
 
 
Scheme 1: Attempted synthesis of 2-bromo-1,4-dihydroxyphenol 1 
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Scheme 2: Synthesis of 2-bromo-1,4-diacetoxybenzene 3 
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Scheme 3: Synthesis of tributyl farnesyl stannane 4  
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Scheme 4: Synthesis of 1,4-diacetoxy-2-farnesylbenzene 6 
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Scheme 5: Synthesis of 2-farnesyl-1,4-dihydroxyphenol 4-HFP 
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Scheme 6: Synthesis of 4-amino-3-bromo-5-methoxyphenol 7 
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Scheme 7: Synthesis of 4-amino-5-farnesyl-3-methoxyphenol IDDMQ3H2 
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Scheme 8: Synthesis of 5-farnesyl-3-methoxybenzoquinone DDMQ3 
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Scheme 9: Synthesis of 5-farnesyl-3-methoxy-6-methylbenzoquinone DMQ3 
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Introduction: 
 
Coenzyme Q (Q or ubiquinone) is an essential lipid composed of a fully substituted 
benzoquinone ring moiety and a polyisoprenoid tail that plays a critical role as an electron 
transporter in the mitochondrial respiratory chain and in the plasma membrane of Escherichia 
coli (1, 2). The polyisoprenoid tail of Q is made up of a variable number of isoprenyl units 
depending on the species (six for Saccharomyces cerevisiae, eight for E. coli, nine for mouse, 
and ten for human, hence Q10). Coenzyme Q is generally biosynthesized from 4-hydroxybenzoic 
acid (4HB) in S. cerevisiae (yeast) (3). However, yeast can also use p-aminobenzoic acid 
(pABA) as another primary precursor of Q (4, 5). As reported in Chapter 3, Kaempferol can act 
as an alternate Q ring precursor in mammalian cells but not in yeast. However, in the quest for 
alternate ring precursors of Q in yeast, studies were able to identify two other phenolic 
compounds, resveratrol and p-coumaric acid that can be utilized to produce Q in yeast (6).  
 
Between resveratrol and p-coumaric acid, the latter turned out to be of considerably more interest 
as an alternate Q ring precursor since it was identified as an intermediate in the biosynthesis of 
4HB in Arabidopsis thaliana (7). Plant peroxisomes contain thiolases and CoA thioesterases that 
are capable of ultimately producing 4HB from 4-hydroxybenzoyl-CoA (7, 8). Tyrosine (Tyr) can 
also successfully supply the ring of Q in Arabidopsis; but it is surmised that this occurs through a 
parallel pathway, because Arabidopsis mutants that are unable to utilize phenylalanine (Phe) are 
still capable of utilizing Tyr in the biosynthesis of Q. Yeast is not able to hydroxylate Phe to 
form Tyr, and it therefore it was inferred that the conversion of tyrosine to 4HB occurs via its 
metabolism to p-coumaric acid (9, 10). However, 4HB biosynthesis in yeast and the exact role p-
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coumaric acid plays as a Q ring precursor still remain largely obscure. Only recently were studies 
able to identify the first and penultimate steps involved in the conversion of tyrosine to 4HB in 
yeast (11, 12). These reports identified the penultimate step in the biosynthesis of 4HB to be the 
oxidation of 4-hydroxybenzaldehyde (4HBz) catalyzed by the alcohol dehydrogenase Hfd1. The 
formation of 4HBz, however, could not be related to p-coumaric acid.  
 
Therefore, more detailed studies were made on the exact role p-coumaric acid plays in Q 
biosynthesis in yeast. Particularly, further insight was required regarding the uptake of 
exogenously added p-coumaric acid and its subsequent conversion to Q. Attempts were also 
made to delve into the possibility of p-coumaric acid acting as an intermediate in the 4HB 
pathway, and to investigate multiple potential pathways involving p-coumaric acid as a Q 
precursor with or without 4HBz and/or 4HB acting as an intermediate.  
 
Results: 
 
In order to study the uptake of p-coumaric acid and its conversion to Q in yeast, [13C6-ring]-p-
coumaric acid (13C-P) was chemically synthesized (Scheme 1). The synthesis was achieved by a 
Perkin type reaction using commercial [13C6-ring]-4-hydroxybenzaldehyde (
13C-4HBz) and 
malonic acid (2) as the starting reactants. BY4741 WT and W303 WT yeast strains were then 
grown in four different types of media: YP-Dextrose (YPD), YP-Glycerol (YPG), Synthetic 
dextrose-complete (SD-complete) and Drop out dextrose with ammonium sulfate without pABA 
without folate (DOD). Initially the rates of growth of the two different WT yeast strains were 
tested in the four media types to ascertain the best time points for subsequent labeling with 13C-P 
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in order to measure its conversion to Q. The yeast strains were inoculated in the corresponding 
media at an initial optical density of 0.2 and the subsequently optical densities were measured in 
2 hour increments after the strains were allowed to finish one doubling period and reach an 
optical density of 0.4-0.5. The corresponding growth curve observed in YPD (Figure 1A) 
showed logarithmic rate of growth initially which eventually slowed down and reached late 
logarithmic growth phase between the 8 and 10 hour time points in YPD. However, in YPG 
(Figure 1B) the logarithmic growth phase was observed to continue without a marked reduction 
in growth rate even up to the 10 hour time point. The growth curves observed in SD-complete 
and DOD (Figure 2, A and B) were similar to that in YPD. It was however seen that the W303 
WT strain had vastly lower optical densities when growing in the DOD media compared to the 
BY4741 WT, even though the growth trend were similar between the two strains (Figure 2B).  
 
The previous growth assays showed that adding the label 13C-P when the cells are at an optical 
density of 0.4-0.5 and subsequently collecting and pelleting the labeled samples over a 10 hour 
time period in increments of 2 hours would fit optimally within the logarithmic range of growth. 
Therefore, fresh yeast stocks of both the BY4741 WT and W303 WT strains were inoculated in 
fresh YPD, YPG, SD-complete and DOD media at a starting optical density of 0.2. Once the 
yeast had reached an optical density of 0.4-0.5, the label 13C-P was added and the the samples 
were collected and pelleted at 2, 4, 6, 8 and 10 hour times points after labeling. The samples 
were then subjected to lipid extraction and the Q content was analyzed by HPLC-MS/MS 
methods. It was seen that the W303 WT not only had greater endogenous unlabeled Q, but was 
also able to uptake and create de novo [13C6-ring]-Q6 (
13C-Q) from the added label P with much 
higher efficiency than the BY4741 WT in all 4 media tested (Figures 3B, 4B, 5B, 6B). This was 
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a novel result since most previous studies involving p-coumaric acid acting as a Q ring precursor 
in yeast were conducted in BY4741 WT. The de novo 13C-Q content was 10-20 fold lower than 
the endogenous unlabeled Q content in most of the media (Figure 3-6). However, in DOD the 
labeled Q content observed in the W303 WT was almost 25% of the total Q content, proving that 
DOD and W303 WT are the most ideal media and yeast strain, respectively, to study the role of 
p-coumaric acid as a Q ring precursor.  
 
The next goal was to test whether p-coumaric acid is utilized as a Q ring precursor via some 
unknown biosynthetic mechanism that bypasses one or more of the steps catalyzed by the Coq 
proteins. To test this possibility, W303 WT and coq 1-coq11 nulls in the W303 yeast background 
were labeled separately with 13C-P and [13C6-ring]-4-hydroxybenzoic acid (
13C-4HB) and the Q 
levels were quantified after collecting the cells 6 hours after labeling. It was observed that 
coq10Δ and coq11Δ were the only null mutants that produced endogenous unlabeled Q and was 
capable of generating de novo labeled 13C-Q when labeled with both 13C-4HB and 13C-P (Figure 
7, A and B). Furthermore, both the unlabeled and labeled Q contents observed in coq10Δ and 
coq11Δ were comparable to the Q levels in WT (Figure 7). The trends were similar when 
unlabeled and labeled quantities of the late stage Q biosynthetic intermediate demethoxy Q 
(DMQ6) were measured, with the coq10Δ and coq11Δ yeast strains showing similar levels to WT 
(Figure 8, A and B). However, coq7Δ also showed high levels of endogenous and de novo DMQ6 
as well, since DMQ6 is the substrate of Coq7 which is responsible for the ring hydroxylation of 
DMQ. In addition coq10Δ showed some accumulation of both the species of DMQ6.  
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Unsurprisingly most of the coq null strains showed relatively high quantities of the early stage Q 
biosynthetic intermediate 2-hexaprenyl-4-hydroxyphenol (HHB), whereas WT, coq1Δ, coq2Δ, 
coq10Δ, and coq11Δ had no HHB (Figure 9, A and B). 
 
We also wanted to investigate whether p-coumaric acid is capable of increasing total Q levels 
similar to the effect that 4HB treatment has. To test this theory, W303 WT yeast was treated with 
13C-P, 13C-4HB, 4HB, p-coumaric acid and EtOH to serve as vehicle control. When the Q 
content in the cells were subsequently analyzed after harvesting the cells 6 hours post-treatment, 
it was seen that both 13C-4HB and 4HB increases the total Q content compared with EtOH 
treatment (Figure 10). However, treatment with 13C-P and p-coumaric acid does not have the 
same effect and the total Q levels are similar to the vehicle control samples.  
 
Finally, we wanted to determine whether p-coumaric acid is somehow involved in the 
biosynthesis of 4HB via the Hfd1 catalyzed 4Hbz oxidation. To test this possibility the HFD1 
gene was silenced and hfd1Δ was created in the W303 yeast genetic background. The latter was 
labeled separately with 13C-4HB, 13C-4HBz and 13C-P, and the samples were collected 5, 10, and 
24 hours after addition of the label. The corresponding de novo Q contents were compared with 
W303 WT treated under similar conditions (Figure 11). Upon quantification of the labeled [13C6-
ring]-Q6  content in the cells via HPLC-MS/MS, no significant differences were seen between the 
two strains when they were labeled with 13C-4HB. Unsurprisingly, the hfd1Δ mutant had 
significantly lower [13C6-ring]-Q6 than the WT when labeled with 
13C-4HBz. In particular it was 
intriguing that the hfd1Δ mutant also had a significantly lower value of [13C6-ring]-Q6 content 
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than the WT at the 5 hour time point when both strains were labeled with 13C-P. However, at the 
10 and 24 hour time points, the [13C6-ring]-Q6 levels are not significantly different between the 
WT and the mutant.  
 
Discussion: 
 
P-coumaric acid had been previously identified as a Q ring precursor in yeast (6). It had also 
been identified as an intermediate in the biosynthesis of 4HB in plants, where it was shown to be 
an intermediate in the biosynthesis of 4HB from Tyr that occurs in the peroxisome via a beta-
oxidative pathway (7). However, such a correlation has not been successfully made in yeast so 
far. The exact mechanism by which p-coumaric acid acts as a Q ring precursor in yeast is still 
unknown. Previous to this study, a comprehensive time and media dependent assay with p-
coumaric acid had not been conducted in yeast. First we were able to show that the ideal time of 
growth during which to conduct a labeling study would be 10 hours post-labeling to capture the 
yeast within the logarithmic growth phase. We then grew WT yeast from the two different 
genetic backgrounds – BY4741 and W303, in four different types of media – YPD, YPG, SD-
complete and DOD. Both the WT strains showed generation of 13C-Q in all four media types 
across all the five time points chosen. However, we were able to come to the novel conclusion 
that the W303 genetic background of yeast is much more efficient at uptaking and converting p-
coumaric acid into Q. A potential reason for this observation is the fact that the W303 genetic 
background of yeast is more efficient at cellular respiration, as corroborated by the higher overall 
Q levels compared to BY4741. Therefore, the former is possibly more efficient at utilizing 
substrates and intermediates that aid in cellular respiration, which potentially includes p-
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coumaric acid. We were also able to conclude that generation of 13C-Q from 13C-P is the most 
efficient in DOD media and 6-8 hours after addition of the label. 
 
Questions still remain regarding the mechanistic details through which the aforementioned 
conversion occurs. It was postulated that p-coumaric acid gets converted to Q via intermediary 
conversion to 4HB through a beta-oxidative pathway. However, the biosynthesis of 4HB in yeast 
is still largely uncharacterized and only recently the alcohol dehydrogenase Hfd1 was identified 
as one of the enzymes involved. However, the beta-oxidation pathway studied in plants that 
involves p-coumaric acid as a 4HB intermediate, does not involve Hfd1 homologs or 4HBz the 
substrate of Hfd1. We conducted a number of experiments to determine whether p-coumaric acid 
is involved in 4HB biosynthesis. First, we labeled coq null mutants in the W303 background 
with 13C-P and observed no uptake of the label for any of the inherently Q-less coq null mutants. 
Therefore, it can be concluded that p-coumaric acid is not able to bypass the Q biosynthesis 
pathway deriving from 4HB. We also showed that unlike 4HB which is able to increase total Q 
levels in yeast compared to vehicle control, p-coumaric acid does not produce any such 
enhancement of Q content. All of these observations potentially strengthen the hypothesis that p-
coumaric acid is indeed metabolized into 4HB in yeast by some unknown mechanism.  
 
Since Hfd1 is one of the few enzymes that have actually been illustrated to be directly linked to 
4HB biosynthesis in yeast, we decided to silence the HFD1 gene in the W303 yeast genetic 
background. The hfd1Δ strain thus created was tested alongside W303 WT to compare and 
contrast the relative production of unlabeled Q and de novo stable isotope labeled 13C-Q upon 
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treatment with 13C-4HB, 13C-4HBz, and 13C-P. The unlabeled Q content was discovered to be 
similar between the WT and the mutant at all time points when treated with 13C-4HB or 13C-P. 
However, labeling the cells with 13C-4HBz resulted in significantly lower endogenous unlabeled 
Q in the hfd1Δ compared to the WT. This is possibly due to the fact that Hfd1 catalyzes the 
oxidation of 4HBz to 4HB, and therefore treatment with isotope labeled 4HBz, is unable to 
restore endogenous Q levels to the same extent as treatment with stable isotope labeled 4HB or 
p-coumaric acid. Unsurprisingly, the de novo labeled 13C-Q content was significantly reduced in 
the hfd1Δ across all the time points (5, 10 and 24 hour post addition of the label) compared to the 
WT when both were labeled with 13C-4HBz, since the mutation is deleterious for the conversion 
of 13C-4HBz to 13C-4HB and in turn 13C-Q. Conversely, labeling with 13C-4HB produced no 
significant differences in 13C-Q levels between the WT and the mutant.  
 
Interestingly, upon 13C-P treatment there was a significant reduction of 13C-Q content in the 
hfd1Δ mutant compared to the WT at the 5 hour time point, an affect that gets ameliorated at the 
later time points. This could potentially further add weight to the proposition that p-coumaric 
acid serves as a Q ring precursor via the 4HBz pathway as well as other alternate pathways that 
may lead to 4HB. The former predominantly occurs at the early periods of yeast growth that may 
include the early to mid-log phase, whereas during late-log or stationary phase of growth the 
yeast might switch to some alternate unknown pathway of converting p-coumaric acid to 4HB 
and in turn to Q. In the future, potential yeast homologs of the plant enzymes identified to play a 
role in the conversion of p-coumaric acid to Q via beta oxidation, can be identified and deleted. 
The null strains thus created can be tested via similar labeling assays to shed further light into the 
role of p-coumaric acid as a Q ring precursor in yeast.  
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Materials and methods: 
 
Chemicals and reagents 
[13C6-ring]-4-hydroxybenzaldehyde (
13C-4Hbz) and [13C6-ring]-4-hydroxybenzoic acid (
13C-
4HB) were ordered from Cambridge Isotopes Inc. All other reagents and solvents required for 
organic synthesis were obtained from Sigma-Aldrich. All yeast media and supplies were 
obtained from Thermo Fischer Scientific. Primers for PCR reactions required for Hfd1 gene 
silencing were ordered from Eurofins Genomics.  
Synthesis of [13C6-ring]-p-coumaric acid  
The synthesis of [13C6-ring]-p-coumaric acid 13C-P was carried out as described in (6) with 
minor modifications. Briefly, to a flame dried round bottom flask (50 ml) was added [13C6-ring]-
4-hydroxybenzaldehyde (13C-4HBz, 300 mg, 2.5 mmol), malonic acid (450 mg, 4.3 mmol), 
piperidine (30 µl), and pyridine (6 ml). The reaction mixture was stirred under nitrogen at 92°C. 
The reaction was monitored through thin layer chromatography on 0.25 mm SiliCycle silica gel 
plates and visualized under UV light and with permanganate or 2,4-dinitrophenylhydrazine 
staining. Upon completion (48 hours), the mixture was sequentially added to 20 ml water, 
neutralized to pH 7–8, and then washed with dichloromethane. The aqueous solution was 
acidified to pH 1 and then extracted twice using 20mL ethyl acetate. The combined organic 
extract was concentrated in vacuo and purified through flash column chromatography. Flash 
column chromatography was performed with SiliCycle Silica-P Flash silica gel (60 Å pore size, 
40–63 µm) and 50% ethyl acetate in hexanes as mobile phase, to furnish an off-white solid (328 
mg, 82% yield). The product was further purified by preparatory HPLC in an Agilent 1200 LC 
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system, using a Waters Sunfire C18 Column (19 mm x 250 mm). The elution gradient used: 40-
55% Acetonitrile +0.1% Trifluoroacetic acid, 2-7 min; Flow rate: 20 mL/min; Monitored at 254 
nm. Fractions were pooled, concentrated in vacuo, and the aqueous remainder was lyophilized to 
give a white powder (291 mg, 73% final yield). NMR spectra were recorded using a Bruker 
Avance-400 spectrometer, calibrated to residual acetone-d6 as the internal reference (2.05 ppm 
for 1H NMR; 29.9 and 206.7 ppm for 13C NMR. 1H NMR (400 MHz, acetone-d6 ) δ: 9.40 (br s, 
1H), 7.70–7.65 (m, 1H), 7.63–7.57 (m, 1H), 7.39–7.34 (m, 1H), 7.05–7.02 (m, 1H), 6.71–6.69 
(m, 1H), 6.32 (dd, J  = 5.2, 16.1 Hz, 1H); 13C NMR (90 MHz, acetone-d6 ) δ: 159.5, 129.9, 
125.9, 115.6. GC-MS data were recorded using an Agilent 6890-5975 GC mass spectrometer 
equipped with an auto-sampler and an HP5 column; the sample was dissolved in ethanol. GC-
MS (EI+) calcd for [13C6
12C3H8O3]
+, m/z 170.1, found 170.1. 
Strains and growth media 
Sachharomyces cerevisiae strains used in this study are listed in Table 1. Liquid media was 
prepared as described in (13) and included: YPD (2% glucose, 1% yeast extract, 2% peptone), 
YPG (3% glycerol, 1% yeast extract, 2% peptone), Synthetic dextrose with all components 
added (SD-complete), and drop out dextrose (DOD) (2% dextrose, 6.8 g/l yeast nitrogen base 
minus pABA minus folate with ammonium sulfate (MP Biomedicals), 5.83 mM sodium 
monophosphate (pH adjusted to 6.0 with NaOH), amino acids and nucleotides added as 
described). Solid plate medium included the stated components plus 2% Bacto agar. The pRS303 
plasmid was obtained in Escherechia coli strain DH5α.  
HFD1 null strain construction 
The HFD1 deletion was introduced in W303-1A WT yeast using a PCR based deletion strategy 
(14) and primers: 
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5’ATCTAAAAGGAATATTCTAAAACCATAGCCATAGTAATTTATCACCAACTCTATTA
CTCTTGGCCTCCTCTAG3’ (Forward) 
5’ACGAAAGGTTACTTATACATCAAATAATTAATTAACCTTAAACATTACGTTCGGTG
TCACTACATAAGAACACC3’ (Reverse) 
The Phusion High-Fidelity DNA Polymerase and HF buffer (Thermo Scientific, USA) was used 
to perform the PCR reactions using conditions described in (14). The PCR fragment obtained 
from the selected plasmid was transformed into W303-1A WT yeast and corresponding colonies 
were plated on selective plate media. The final HFD1 deletion and integration of the plasmid was 
verified by PCR and genomic sequencing.  
Preparation of stock solutions for labels added 
The stable isotope labeled compounds 13C-4HB and 13C-P, along with the unlabeled compounds 
4HB and p-coumaric acid were freshly dissolved in EtOH. The concentration of each stock 
solution thus obtained were adjusted so that addition of 9 µL of each corresponding EtOH stock 
solution in 6 mL YPD liquid media would result in a final concentration of 50 mg/L for each 
compound. 
Yeast labeling assay 
Yeast colonies from YPD plate medium were first inoculated into 125 mL Erlenmeyer flasks 
containing 30 mL YPD, YPG, SD-complete, or DOD liquid media. Following overnight 
incubation with shaking (250 rpm) at 30 oC, the yeast cells were added into 18x150 mm 
borosilicate test tubes, containing fresh 6mL liquid media of the same type that the overnight 
pre-culture was incubated in. The inoculation during this step was performed so that the final 
OD600 of the yeast cells in 6mL liquid media in each test tube is 0.2. These tubes were further 
incubated by shaking (250 rpm) at 30 oC slanted at a 45o angle. The OD600 of the yeast cultures 
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in the test tubes were monitored till an OD600 of 0.4-0.5 was reached. At that time point 9 µL of 
the EtOH stock solutions of the compounds of interest were added to the tubes so that the final 
concentrations of the compounds in 6 mL liquid media was achieved to be 50 mg/L. The tubes 
with the yeast were incubated with shaking under the same conditions as mentioned previously. 
At the selected time after addition of the treatments, the tubes were removed from the incubator. 
The OD600 at each time point for each yeast sample was measured, 5mL of the vortexed liquid 
yeast culture was withdrawn into fresh 10mL centrifuge tubes. The tubes were centrifuged at 
3000xg rpm for 5 minutes, and the liquid media was aspirated out to obtain yeast cell pellets. 
The pellets thus obtained were stored at -20 oC. The experiment was conducted in triplicates for 
each time point, yeast strain and treatment added.  
Lipid extraction of yeast cell pellets 
Lipid extractions of the yeast cell pellets were performed similar to the description in (13). 
Briefly the cell pellets were thawed on ice and then suspended in 2 mL of methanol. Q4 was 
added as an internal standard for the determination of Q6 content in the lipid extracts. The tubes 
were vortexed at maximum intensity for 30 seconds followed by addition of 2 mL of petroleum 
ether. This was followed by another round of vortex as before, after which the upper petroleum 
ether layer was removed from the phase boundary and transferred to a fresh tube. The petroleum 
ether addition, vortex, and removal of the upper petroleum ether layer was repeated for a total of 
two cycles. The petroleum ether solutions were consolidated for each sample, and the solvent 
was evaporated under a stream of nitrogen gas. 
HPLC-MS/MS analysis to measure Q and Q intermediates  
The HPLC-MS/MS analysis to quantify Q from the yeast lipid extracts previously obtained was 
carried out as described in (13) with minor modifications. Briefly, the dry lipid extracts were first 
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resuspended in 200 µL benzoquinone solution (0.1 mg/mL in EtOH). This was done to ensure 
complete oxidation of all the lipids which simplifies the subsequent detection and quantification 
process. A 4000 QTRAP linear MS/MS spectrometer from Applied Biosystems (Foster City, 
CA) was used. Applied Biosystem software, Analyst version 1.4.2, was used for data acquisition 
and processing. A binary HPLC solvent delivery system was used with a Luna phenyl-hexyl 
column (particle size 5 µm, 100 × 4.60 mm; Phenomenex) for yeast cell lipid extracts. The 
mobile phase consisted of solvent A (methanol:isopropanol, 95:5, with 2.5 mM ammonium 
formate) and solvent B (isopropanol, 2.5 mM ammonium formate). For separation of yeast 
quinones, the percentage of solvent B increased linearly from 0 to 5% over 6 min, and the flow 
rate increased from 600 to 800 µL/ min. The flow rate and mobile phase were linearly changed 
back to initial condition by 7 min. All samples were analyzed in multiple reaction monitoring 
mode; multiple reaction monitoring transitions were as follows: m/z 591/197.1 (Q6); m/z 
608/197.1 (Q6 with ammonium adduct); m/z 597/203.1 (
13C-Q6); m/z 614/203.1 (
13C-Q6 with 
ammonium adduct); m/z 561.6/167 (DMQ6); m/z 578.6/167 (DMQ6 with ammonium adduct); m/z 
567.6/173 (13C-DMQ6); m/z 584.6/173 (
13C-DMQ6 with ammonium adduct); m/z 547.2/151 
(HHB); m/z 564.2/151 (HHB with ammonium adduct); m/z 553.2/157 (13C-HHB); m/z 570.2/157 
(13C-HHB with ammonium adduct). 
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Table 1. Genotypes and sources of yeast strains 
 
Strain Genotype Source 
BY4741  MAT a his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (15) 
W303-1A MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 R. Rothstein 
W303Δcoq1 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq1::LEU2 (16) 
W303Δcoq2 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq2::HIS3 (17) 
W303Δcoq3 MAT α ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq3::LEU2 (18) 
W303Δcoq4 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq4::TRP1 (19) 
W303Δcoq5 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq5::HIS3 (20) 
W303Δcoq6 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq6::LEU2 (21) 
W303Δcoq7 MAT α ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq7::LEU2 (22) 
W303Δcoq8 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 
abc1/coq8::HIS3 
(19) 
W303Δcoq9 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq9::URA3 (23) 
W303Δcoq10 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq10::HIS3 (24) 
W303Δcoq11 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq10::HIS3 (13) 
W303Δhfd1 MAT a ade2-1 his3-1,15 leu2-3,112 trp1-1 ura3-1 coq10::HIS3 This study 
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Figure 1. Yeast growth curves in YPD and YPG. (A) The growth of BY4741 WT (blue dots) 
and W303 WT (red squares) yeast as observed in YPD (B) The growth of BY4741 WT (blue 
dots) and W303 WT (red squares) yeast as observed in YPD. Error bars represent S.D. (n = 3). 
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Figure 2. Yeast growth curves in SD-complete and DOD. (A) The growth of BY4741 WT 
(blue dots) and W303 WT (red squares) yeast as observed in SD-complete (B) The growth of 
BY4741 WT (blue dots) and W303 WT (red squares) yeast as observed in DOD. Error bars 
represent S.D. (n = 3). 
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Figure 3. Endogenous unlabeled and de novo 13C-labeled Q content in YPD. Q content 
comparison in the yeast samples labeled with [13C6-ring]-p-coumaric acid and grown in YPD. 
(A) Unlabeled Q6 in BY4741 WT (blue) and W303 WT (red). (B) Labeled [13C6-ring]-Q6 in 
BY4741 WT (blue) and W303 WT (red). Statistical significance was calculated by Student’s T-
test (two tailed unequal variance) between red and blue bars for each time point, single asterisk 
represents p value < 0.05. Error bars represent S.D. (n = 3).  
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Figure 4. Endogenous unlabeled and de novo 13C-labeled Q content in YPG. Q content 
comparison in the yeast samples labeled with [13C6-ring]-p-coumaric acid and grown in YPG. 
(A) Unlabeled Q6 in BY4741 WT (blue) and W303 WT (red). (B) Labeled [13C6-ring]-Q6 in 
BY4741 WT (blue) and W303 WT (red). Statistical significance was calculated by Student’s T-
test (two tailed unequal variance) between red and blue bars for each time point, single asterisk 
represents p value < 0.05. Error bars represent S.D. (n = 3).  
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Figure 5. Endogenous unlabeled and de novo 13C-labeled Q content in SD-complete. Q 
content comparison in the yeast samples labeled with [13C6-ring]-p-coumaric acid and grown in 
SD-complete. (A) Unlabeled Q6 in BY4741 WT (blue) and W303 WT (red). (B) Labeled [13C6-
ring]-Q6 in BY4741 WT (blue) and W303 WT (red). Statistical significance was calculated by 
Student’s T-test (two tailed unequal variance) between red and blue bars for each time point, 
single asterisk represents p value < 0.05. Error bars represent S.D. (n = 3).  
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Figure 6. Endogenous unlabeled and de novo 13C-labeled Q content in DOD. Q content 
comparison in the yeast samples labeled with [13C6-ring]-p-coumaric acid and grown in DOD. 
(A) Unlabeled Q6 in BY4741 WT (blue) and W303 WT (red). (B) Labeled [13C6-ring]-Q6 in 
BY4741 WT (blue) and W303 WT (red). Statistical significance was calculated by Student’s T-
test (two tailed unequal variance) between red and blue bars for each time point, single asterisk 
represents p value < 0.05. Error bars represent S.D. (n = 3).  
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Figure 7. Q content comparison in WT and Coq nulls grown in DOD. W303 WT and Coq 
nulls in the W303 background were labeled with [13C6-ring]-4HB (pink) or [
13C6-ring]-p-
coumaric acid (green). (A) Endogenous unlabeled Q6 levels, and (B) de novo [
13C6-ring]-Q6 
levels. Error bars represent S.D. (n = 3). 
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Figure 8. DMQ6 content comparison in WT and Coq nulls grown in DOD. W303 WT and 
Coq nulls in the W303 background were labeled with [13C6-ring]-4HB (pink) or [
13C6-ring]-p-
coumaric acid (green). (A) Endogenous unlabeled DMQ6 levels, and (B) de novo [
13C6-ring]-
DMQ6 levels. Error bars represent S.D. (n = 3). 
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Figure 9. HHB content comparison in WT and Coq nulls grown in DOD. W303 WT and Coq 
nulls in the W303 background were labeled with [13C6-ring]-4HB (pink) or [
13C6-ring]-p-
coumaric acid (green). (A) Endogenous unlabeled HHB levels, and (B) de novo [13C6-ring]-HHB 
levels. Error bars represent S.D. (n = 3). 
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Figure 10. Q content comparison in W303 WT yeast grown in DOD. The yeast samples were 
treated with [13C6-ring]-4-hydroxybenzoic acid (
13C-4HB), [13C6-ring]-p-coumaric acid (
13C-P), 
4-hydroxybenzoic acid (4HB), and p-coumaric acid. Endogenous unlabeled Q6 levels (grey) and 
de novo [13C6-ring]-Q6 levels (orange) are shown. Statistical significance was calculated by 
Student’s T-test (two tailed unequal variance) between the total Q levels for each treatment 
compared to EtOH (vehicle control), single asterisk represents p value < 0.05. Error bars 
represent S.D. (n = 3).  
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Figure 11. De novo stable isotope labeled Q content comparison in WT and hfd1 null yeast 
labeled with different Q precursors. W303 WT and hfd1Δ mutant in the W303 background 
were grown in DOD liquid media for 5, 10, and 24 h and labeled with [13C6-ring]-4HB (pink), 
with [13C6-ring]-4HBz (orange), or [
13C6-ring]-p-coumaric acid (green). Bars show the de novo 
labeled [13C6-ring]-Q6 content as measured in the yeast under the conditions mentioned (n = 3). 
Statistical significance was calculated by Student’s T-test (two tailed unequal variance) between 
WT and hfd1Δ for each label at each time point, single asterisk represents p value < 0.05. Error 
bars represent S.D. (n = 3). 
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Scheme 1: Synthesis of [13C6-ring]-p-coumaric acid 13C-P. Atoms with red dots represent stable 
isotope 13C-carbons. 
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Introduction: 
 
As shown in previous chapters, Coenzyme Q (Ubiquinone, CoQ, or Q) is a vital molecule made 
up of a redox-active benzoquinone ring and a lipophilic polyprenyl tail. It serves a critical role as 
an electron carrier in cellular respiration, and is ubiquitous in eukaryotes and prokrayotes as well 
as in the photosynthetic reaction center of purple bacteria (1, 2). Ubiquinone also doubles as a 
liposomal chain terminating antioxidant that is capable of protecting neighboring membrane 
bound lipids and proteins from oxidative damage caused by hydroxyl, peroxide and other 
reactive oxygen species (ROS) (3, 4). Furthermore, besides its roles as an electron carrier and an 
antioxidant, evidence has been recently gathered that demonstrates that Q can also serve a solely 
mechanical function by increasing the thickness of biological membranes in response to osmotic 
stress (5). 
 
In most organisms the benzenoid ring precursor of Q is 4-hydroxybenzoic acid (4HB); the only 
exception to date is the yeast Saccharomyces cerevisiae, which can also utilize p-aminobenzoic 
acid (pABA) to generate Q, through a series of prenylation and demination steps that converge 
with the primary Q biosynthetic pathway stemming from 4HB (6). Chapter 3 illustrated the 
discovery of a novel Q ring precursor kaempferol, which belongs to the flavonol class of 
molecules (7). However, the exact metabolic pathway by which kaempferol increases Q levels in 
mammalian cells and gets incorporated into Q biosynthesis was not established. It was postulated 
that kaempferol acts as a Q ring precursor either via cleavage of its structure resulting in 
metabolites that are structurally similar to 4HB, or directly by itself acting as a substrate for the 
Coq2 polyprenyl transferase (Figure 1). The first theory was recently proven to be valid in 
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Arabidopsis thaliana by Dr. Gilles Bassett, who showed that plant peroxidases are responsible 
for the cleavage of kaempferol and the generation of 4HB as a consequence (8). More 
specifically, it was confirmed that the B-ring of kaempferol actually serves as the ring moiety of 
Q via intermediary conversion to 4HB.  
 
We are currently further investigating the metabolism of kaempferol in mammalian cells in order 
to verify whether the B-ring of kaempferol is incorporated into Q, via cleavage and conversion of 
the former into 4HB catalyzed by mammalian peroxidases. Dr. Bassett used a combination of in 
vitro peroxidase assays with plant extracts as well as stable isotope labeling assays to study the 
production of 4HB and Q respectively from kaempferol. Our efforts are being directed at 
developing similar methods to detect and quantify 4HB and Q generated from kaempferol in 
mammalian cells and cell extracts. 
 
Results and discussions: 
 
We first tested whether the B-ring of kaempferol is indeed incorporated as the benzenoid ring of 
Q in mammalian cells. We achieved this by incubating mouse kidney cells (TKPTS) in presence 
of stable isotope labeled [13C6-B-ring]-kaempferol (Figure 2, A). Cellular lipid contents were 
subsequently extracted and subjected to HPLC-MS/MS analysis to quantify endogenous 
unlabeled Q and de novo stable isotope labeled Q levels. It was observed that the TKPTS cells 
grown in presence of [13C6-B-ring]-kaempferol (generated by Dr. Gilles Bassett), successfully 
generated [13C6-ring]-Q9 and [
13C6-ring]-Q10, the major and minor isoforms of Q in murine cells 
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respectively (Figure 2, B and C). As expected, the total Q content was also increased when the 
cells were treated with unlabeled kaempferol, [13Cu]-kaempferol, [
13C6-B-ring]-kaempferol, and 
[13C6-ring]-4HB. Untreated cells and those treated with unlabeled kaempferol showed no [
13C6-
ring]-Q9 and [
13C6-ring]-Q10. All of these results established that it is indeed the B-ring of 
kaempferol that gets converted to Q in mammalian cells as previously hypothesized. The 
incorporation of the stable isotope label of [13C6-B-ring]-kaempferol into Q was lower than that 
of [13Cu]-kaempferol and [
13C6-ring]-4HB. One possibility for this observation could be due to 
the method by which the [13C6-B-ring]-kaempferol was isolated through an in vivo strategy from 
A. thaliana fed with [13C6-ring]-phenylalanine by Dr. Gilles Bassett. As a consequence, the 
actual concentration of [13C6-B-ring]-kaempferol might potentially be lower than the measured 
concentration due to the possibility of the stable isotope label from [13C6-ring]-phenylalanine not 
getting completely incorporated into [13C6-B-ring]-kaempferol by the plants.  
 
With the confirmation of the B-ring of kaempferol being responsible for generating the 
benzenoid head group of Q murine cells, we wanted to further investigate the potential pathway 
by which this process occurs. In particular, we are interested in verifying whether mammalian 
peroxidases are responsible for cleavage of the kaempferol molecule, akin to that observed in 
plants. In order to set up such an in vitro peroxidase assay with mammalian cell extracts to 
analyze the conversion of kaempferol to 4HB, we needed to develop a method for detection and 
quantification of 4HB. We attempted to detect and quantify 4HB directly via HPLC-MS/MS 
methods using negative ion detection mode. However, these attempts proved to be inconsistent 
and unsuccessful, possibly due to the inherent difficulty of 4HB detection via HPLC-MS/MS 
analysis. Thus, we shifted our efforts into developing a method of chemically derivatizing 4HB, 
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followed by subsequent analysis of the derivatized 4HB via HPLC-MS/MS. The derivatization 
of 4HB was performed utilizing a strategy highlighted in a recent study (12). Specifically, dansyl 
chloride (dansyl-Cl) was used as the derivatizing reagent, which is attached on 4HB through a 
base catalyzed SN2 reaction highlighted in Scheme 1, to obtain the derivatized product to be used 
in our HPLC-MS/MS analysis (dansyl-4HB).  
 
With the derivatization of 4HB and generation of dansyl-4HB, the HPLC-MS/MS parameters for 
detecting and quantifying the latter were developed. The precursor (Figure 3) and product ions 
(Figure 4) were selected and optimized along with the elution solvent gradient. Subsequently a 
set of dansyl-4HB standards resuspended in methanol with concentrations ranging from 10 
pg/mL to 10 µg/mL were created using a serial dilution strategy. Figure 5 shows a representative 
chromatogram obtained from the calibration standard sample with concentration 1 ng/mL 
dansyl-Cl run through the HPLC-MS/MS method optimized for dansyl-4HB detection and 
quantification. It was also observed that the sample with the highest concentration of 10 µg/mL, 
fell beyond the linear range of quantification, and was therefore omitted from the calibration 
curve. The curve consequently obtained showed a high degree of linearity (Figure 6). However, 
chromatograms of methanol blanks injected in between each standard sample, started showing 
the peak corresponding to dansyl-4HB when the standard concentration exceeded 100 ng/mL. 
This was attributed to the possible tendency of the dansyl-4HB to adhere to the HPLC column 
and the tubing at higher concentrations. Thus a second set of standards were also created via 
serial dilutions, ranging from 10 pg/mL to 100 ng/mL instead of 10 µg/mL. The calibration curve 
thus obtained had a slightly improved linear regression value (Figure 7), without creating the 
problem of the dansyl-4HB adhering to the HPLC system.  
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With the establishment of the methodology to consistently derivatize 4HB followed by the 
detection, quantification and analysis of the derivatized product dansyl-4HB through HPLC-
MS/MS, we are now at a position to set up in vitro peroxidase assays using mouse kidney cell 
extracts and kaempferol. Currently efforts are being taken to incorporate the in vitro peroxidase 
assay methods used by Dr. Gilles Bassett on plants and set up a similar assay that would be 
compatible with tests on mammalian cells, as well as our derivatization strategy of the product(s) 
of the assay which we are postulating to primarily be 4HB. 
 
Materials and methods: 
 
Chemicals and reagents 
All chemicals required for the derivatization of 4HB were obtained commercially from Sigma-
Aldrich. [13C6-B-ring]-kaempferol was obtained from Dr. Gilles Bassett (University of Florida, 
Gainesville). Other stable isotope labeled compounds were ordered from Cambridge Isotopes 
Inc. Media and other reagents required for mammalian cell cultures and HPLC-MS/MS studies 
were obtained from Thermo-Fischer Scientific.  
Cell cultures  
Mouse kidney proximal tubule epithelial (Tkpts) cells (13), were provided by Dr. Elsa Bello-
Reuss (Texas Tech University Health Science Center) and Dr. Judit K. Magyesi (University of 
Arkansas for Medical Sciences, Little Rock, AR). The cells were grown and cultured according 
to conditions listed in our previous study (7). Briefly, the cells were grown in DMEM/F12 with 
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4.5 g/L glucose supplemented with 10% FBS, 2 mM L-glutamine, and gentamicin-amphotericin 
B (125 μg/ml and 5 mg/ml, respectively). The cultures were maintained at 37 °C in a humidified 
atmosphere with 5% CO2.  
Treatment of Tkpts cells with stable isotope labeled compounds 
The same experimental conditions were used for all compounds when tested in the Tkpts cells. 
Assays were performed as highlighted in (7) with minor modifications. Briefly, twelve-well 
plates with an initial amount of 50,000–100,000 cells/well were used. Cells were incubated with 
the tested compounds for 48 hours under standard culture conditions (37 °C, 5% CO2). Once the 
treatment was completed, cells were detached from culture plates and pelleted by low-speed 
centrifugation (approximately 1,000 g). Cell pellets were collected and stored at −80 °C until 
use. Final concentrations of each compound in assays to determine Q content and biosynthesis 
were kept at 5 µM, except for [13C6-ring]-4HB which was added at a final concentration of 1 
µM.  
Lipid extractions for HPLC-MS/MS measurements 
The Tkpts cell pellets collected after 48 hours of incubation in presence of the compounds 
selected for treatment, were subjected to the lipid extraction protocol described in (7). Briefly, 
dipropoxy-Q10 was added to the pellets as an internal standard. Cell pellets were vortexed in 1 ml 
of methanol and 1 ml of petroleum ether. The organic upper layer was transferred to a new tube. 
Another 1 ml of petroleum ether was added to the original methanol layer, and samples were 
vortexed again. The organic phase was removed, and the combined organic phase was dried 
under a stream of nitrogen gas. 
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HPLC-MS/MS quantification of Q species 
Lipid extracts were measured by HPLC-tandem mass spectrometry (MS/MS) analyses as 
previously described (7). Briefly, the samples were resuspended in 200 μL of ethanol containing 
1 mg/ml benzoquinone in order to oxidize all the lipids. Chromatographic separation was 
achieved through a reverse phase Luna 5µM PFP(2) column (Phenomenex) with a mobile phase 
composed of 90% solvent A (95:5 mixture of methanol:isopropanol containing 2.5 mM 
ammonium formate) and 10% solvent B (isopropanol containing 2.5 mM ammonium formate) at 
a constant flow rate of 1 ml/min. Transitions monitored are described in Table 1. The area value 
of each peak, was normalized with the corresponding standard curve and internal standard, with 
a reference to the total protein content of the cells serving as the denominator.  
Derivatization of 4HB by dansyl-Cl 
The derivatization of 4HB by dansyl-Cl was performed as described in (12), with minor 
modifications. Briefly, stock solutions of 4HB (1mg/mL in acetone), dansyl-Cl (0.5mg/mL in 
acetone) and NaHCO3 (200 µM in water) were first prepared. The stock solution of 4HB was 
serially diluted to achieve the required final concentration (10 µg/mL or 1 µg/mL in acetone). To 
100 µL of this solution of 4HB in a 1.5 mL Eppendorf tube was added 200 µL of the dansyl-Cl 
stock solution, followed by 200 µL of the NaHCO3 stock solution. The tube was vortexed at high 
speed for 30 seconds, followed by incubation in a water bath maintained at 60 oC for 20 minutes, 
at which point discoloration of the solution showed completion of the reaction (quantitative yield 
of dansyl-4HB was assumed). After that, 500 µL of ethyl acetate was added, the tube was 
vortexed at maximum speed for 1 minute, centrifuged at 10,000 g for 30 seconds, and the upper 
ethyl acetate layer pipetted out into a fresh centrifuge tube. The step above was repeated for a 
total of two consecutive ethyl acetate extractions. The extracts were combined in the fresh 
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centrifuge tube and dried by passing a stream of N2 gas. The dried extract was resuspended in 1 
mL methanol and serially diluted to obtain a linear range of dansyl-4HB concentrations, with an 
upper limit of 10 µg/mL or 100 ng/mL to a lower limit of 10 pg/mL.  
Detection and quantification of dansyl-4HB by HPLC-MS/MS 
An API 4000 linear MS/MS spectrometer from Applied Biosystems (Foster City, CA) was used. 
Applied Biosystem software, Analyst version 1.4.5, was used for data acquisition and 
processing. An Agilent 1100 series binary HPLC solvent delivery system was used with a 
reverse phase Gemini-NX 5µ C18 column (particle size 5 µm, 100 × 3 mm; Phenomenex) for 
analyzing the dansyl-4HB standards. The mobile phase consisted of solvent A (H20, with 0.1% 
formic acid) and solvent B (acetonitrile, with 0.1% formic acid). The solvent flow rate was kept 
constant at 200 µL/ min, with a total run time of 7 minutes and the injection volume for the 
samples was set at 10 µL. From 0 to 0.5 minutes, solvent A was used at 90% and solvent B at 
10%. The percentage of solvent B increased linearly from 10 to 99% over from 0.5 to 3 minutes, 
and was kept constant from 3 to 4.5 minutes.  Then the percentage of Solvent A was increased 
linearly from 1% to 90% and that of solvent B decreased back down to 10% from 4.5 to 5 
minutes. This ratio of the two solvents was maintained from 5 to 7 minutes. The samples were 
analyzed in multiple reaction monitoring mode with the detection set for m/z 372.3/171.2. The 
values for the MS detection parameters were optimized by direction injection of dansyl-4HB in 
positive ion mode, and were set at the following values: declustering potential (DP) - 131 v, 
entrance potential (EP) - 10 v, collision energy (CE) - 37 v, and cell collision exit potential 
(CXP) - 12 v.  
 
 
106 
 
Table 1. Summary of all the Q analytes and the corresponding precursor-product ion 
masses detected during the HPLC-MS/MS quantification of cellular lipid extracts 
 
Molecule 
 
m/z (+ H) m/z (+ NH3) 
 
Q9 795.6/197.08 
 
 
812.6/197.08 
[13C6-ring]-Q9 801.6/203.08 
 
818.6/203.08 
 
 
Q10 863.6/197.08 
 
 
880.6/197.08 
 
 
[13C6-ring]-Q9 869.6/203.08 
 
 
886.6/203.08 
 
 
Dipropoxy-Q10 919.7/253.1 
 
 
936.7/253.1 
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Figure 1. Possible routes for conversion of kaempferol to Q. Kaempferol can undergo 
molecular cleavage (represented by the black scissors) to yield potential Q precursors that may 
include 4-hydroxybenzoic acid (4HB), which can get prenylated by Coq2 and enter the Q 
biosynthetic pathway catalyzed by the Coq proteins (represented by the red dotted arrows). 
Conversely, kaempferol might get directly prenylated by Coq2 and undergo other 
transformations to yield Q. Red question marks represent potential steps catalyzed by unknown 
enzymes.  
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A 
                                                
B            C 
                                                                             
 
Figure 2. Effect of [13C6-B-ring]-kaempferol treatment on mouse Tkpts cells. Mouse Tkpts 
cells were grown in presence of (A) [13C6-B-ring]-kaempferol (
13C-B ring-K). Untreated cells 
served as negative control, along with cells treated with unlabeled kaempferol (K). [13Cu]-
kaempferol (13C-K) and [13C6-ring]-4-hydroxybenzoic acid (
13C-4HB) served as positive 
controls. (B) Unlabeled (white bars) and labeled [13C6-ring]-Q9 (purple bars), and (C) unlabeled 
(white bars) and labeled [13C6-ring]-Q10 (pink bars) content is shown. Statistical significance was 
calculated using Student’s T-test (two tailed, unequal variance). Asterisks represent p value < 
0.05. Error bars represent S.D. (n = 6). 
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Figure 3. Precursor ion chromatogram of dansyl-4HB. Direct injection of dansyl-4HB to 
optimize the HPLC-MS/MS parameters produced corresponding precursor ion peak at [m/z + 1] 
= 372.3. 
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Figure 4. Product ion chromatogram of dansyl-4HB. Direct injection of dansyl-4HB to 
optimize the HPLC-MS/MS parameters produced the the major product ion peak at [m/z + 1] = 
171.2.  
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Figure 5. Representative chromatogram of dansyl-Cl standard sample with concentration 1 
ng/mL. The corresponding transition being monitored from the precursor to the product ion is 
shown.  
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Figure 6. Dansyl-Cl standard calibration curve 1. The concentration of the standards plotted 
on the curve ranged from 10 pg/mL to 1 µg/mL. 
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Figure 7. Dansyl-Cl standard calibration curve 2. The concentration of the standards plotted 
on the curve ranged from 10 pg/mL to 100 ng/mL. 
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Scheme 1. Synthesis of dansyl-4-hydroxybenzoic acid (dansyl-4HB).  
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Appendix I 
 
Chromatin-remodeling SWI/SNF complex regulates Coenzyme Q6 synthesis and a 
metabolic shift to respiration in yeast 
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Appendix II 
 
Treatment with 2,4-dihydroxybenzoic acid prevents progression of FSGS and renal fibrosis 
in podocyte-specific Coq6 knockout mice 
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